IFAM
TEVA icon

Institutional & Family Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Institutional & Family Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.95K Buy
+120
New +$1.85K ﹤0.01% 582
2023
Q2 		– Sell
-2,000
Closed -$17.7K – 791
2023
Q1 		$17.7K Buy
+2,000
New +$19.8K ﹤0.01% 325

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Institutional & Family Asset Management's TEVA Position: Q2 2024 in Review

Institutional & Family Asset Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2024: 120 shares worth $1.95K. The stake represents ﹤0.01% of the portfolio and ranks #582 among its holdings. This is a return to the name: Institutional & Family Asset Management previously reported a position in TEVA as recently as Q1 2023.

Institutional & Family Asset Management first reported a position in TEVA in Q1 2023 and has held it in 2 quarters since. The position peaked at $17.7K in Q1 2023. 534 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • Institutional & Family Asset Management held 120 shares of Teva Pharmaceuticals worth $1.95K as of Q2 2024.
  • Teva Pharmaceuticals was a new Institutional & Family Asset Management position in Q2 2024.
  • Teva Pharmaceuticals made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #582 holding.
  • Institutional & Family Asset Management first reported a position in Teva Pharmaceuticals in Q1 2023 and has held it in 2 quarters since.
  • Institutional & Family Asset Management's Teva Pharmaceuticals position peaked at $17.7K in Q1 2023.
  • 534 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.